These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 10325401)

  • 1. Structural Insights into the Inhibition of the Extended-Spectrum β-Lactamase PER-2 by Avibactam.
    Ruggiero M; Papp-Wallace KM; Brunetti F; Barnes MD; Bonomo RA; Gutkind G; Klinke S; Power P
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Insights into the TLA-3 Extended-Spectrum β-Lactamase and Its Inhibition by Avibactam and OP0595.
    Jin W; Wachino JI; Yamaguchi Y; Kimura K; Kumar A; Yamada M; Morinaka A; Sakamaki Y; Yonezawa M; Kurosaki H; Arakawa Y
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Landscape of Diazabicyclooctane (DBO) Inhibition: Avibactam Inactivation of PER-2 β-Lactamase.
    Ruggiero M; Papp-Wallace KM; Taracila MA; Mojica MF; Bethel CR; Rudin SD; Zeiser ET; Gutkind G; Bonomo RA; Power P
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Mutations at Arg220 and Thr237 in PER-2 β-Lactamase on Conformation, Activity, and Susceptibility to Inhibitors.
    Ruggiero M; Curto L; Brunetti F; Sauvage E; Galleni M; Power P; Gutkind G
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.
    Philippon A; Slama P; Dény P; Labia R
    Clin Microbiol Rev; 2016 Jan; 29(1):29-57. PubMed ID: 26511485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinations.
    Kurz SG; Wolff KA; Hazra S; Bethel CR; Hujer AM; Smith KM; Xu Y; Tremblay LW; Blanchard JS; Nguyen L; Bonomo RA
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6085-96. PubMed ID: 24060876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.
    Papp-Wallace KM; Taracila M; Hornick JM; Hujer AM; Hujer KM; Distler AM; Endimiani A; Bonomo RA
    Antimicrob Agents Chemother; 2010 Jul; 54(7):2867-77. PubMed ID: 20421396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and biochemical evidence that a TEM-1 beta-lactamase N170G active site mutant acts via substrate-assisted catalysis.
    Brown NG; Shanker S; Prasad BV; Palzkill T
    J Biol Chem; 2009 Nov; 284(48):33703-12. PubMed ID: 19812041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognition.
    De Wals PY; Doucet N; Pelletier JN
    Protein Sci; 2009 Jan; 18(1):147-60. PubMed ID: 19177359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.
    Petrella S; Ziental-Gelus N; Mayer C; Renard M; Jarlier V; Sougakoff W
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3725-36. PubMed ID: 18625772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization of PER-2 and genetic environment of blaPER-2.
    Power P; Di Conza J; Rodríguez MM; Ghiglione B; Ayala JA; Casellas JM; Radice M; Gutkind G
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2359-65. PubMed ID: 17438050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases.
    Paterson DL; Hujer KM; Hujer AM; Yeiser B; Bonomo MD; Rice LB; Bonomo RA;
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3554-60. PubMed ID: 14576117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel class A beta-lactamase Sed-1 from Citrobacter sedlakii: genetic diversity of beta-lactamases within the Citrobacter genus.
    Petrella S; Clermont D; Casin I; Jarlier V; Sougakoff W
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2287-98. PubMed ID: 11451687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in Brazil.
    Bonnet R; Sampaio JL; Chanal C; Sirot D; De Champs C; Viallard JL; Labia R; Sirot J
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3061-8. PubMed ID: 11036023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-directed mutagenesis of residues 164, 170, 171, 179, 220, 237 and 242 in PER-1 beta-lactamase hydrolysing expanded-spectrum cephalosporins.
    Bouthors AT; Delettré J; Mugnier P; Jarlier V; Sougakoff W
    Protein Eng; 1999 Apr; 12(4):313-8. PubMed ID: 10325401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of residues 104, 164, 166, 238 and 240 in the substrate profile of PER-1 beta-lactamase hydrolysing third-generation cephalosporins.
    Bouthors AT; Dagoneau-Blanchard N; Naas T; Nordmann P; Jarlier V; Sougakoff W
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1443-9. PubMed ID: 9494118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the extended-spectrum β-lactamase PER-2 and insights into the role of specific residues in the interaction with β-lactams and β-lactamase inhibitors.
    Ruggiero M; Kerff F; Herman R; Sapunaric F; Galleni M; Gutkind G; Charlier P; Sauvage E; Power P
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5994-6002. PubMed ID: 25070104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed mutagenesis of beta-lactamase TEM-1. Investigating the potential role of specific residues on the activity of Pseudomonas-specific enzymes.
    Lenfant F; Petit A; Labia R; Maveyraud L; Samama JP; Masson JM
    Eur J Biochem; 1993 Nov; 217(3):939-46. PubMed ID: 8223651
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.